Association between neurodegenerative plasma biomarkers and geriatric depression in older adults with and without clinical dementia in Kinshasa, Democratic Republic of the Congo
Zusammenhang zwischen neurodegenerativen Plasma-Biomarkern und geriatrischer Depression bei älteren Erwachsenen mit und ohne klinische Demenz in Kinshasa, Demokratische Republik Kongo
Frontiers in Psychiatry · 22.05.2026 · 17
DOI: 10.3389/fpsyt.2026.1787247 ↗Auf einen Blick
Bei 81 älteren Erwachsenen waren GFAP und NfL mit höheren Chancen für geriatrische Depression assoziiert. Andere Biomarker zeigten keinen Zusammenhang.
Fragestellung
Besteht bei älteren Erwachsenen mit und ohne klinische Demenz ein Zusammenhang zwischen neurodegenerativen Plasma-Biomarkern und geriatrischer Depression?
Methode
Querschnittstudie mit 81 Personen ab 65 Jahren in Kinshasa. Demenz-, Depressions- und Kognitionstestung; logistische Regression, adjustiert für Geschlecht, Alter und Bildung.
Ergebnisse
GFAP: OR 1,98 (95 %-KI 1,17–3,67; p=0,02). NfL: OR 1,76 (95 %-KI 1,06–3,20; p=0,04). Andere Biomarker waren nicht mit Depression assoziiert.
Schlussfolgerung der Autor:innen
Die Studie deutet auf eine mögliche Rolle unspezifischer AD-Biomarker, neurodegenerativer Marker und astrozytärer Gliaaktivierung bei geriatrischer Depression hin.
Kernaussagen
- GFAP und NfL waren mit höherer Depressionswahrscheinlichkeit assoziiert
- Andere gemessene Biomarker zeigten keinen Zusammenhang
- Untersucht wurden ältere Erwachsene mit und ohne klinische Demenz
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 22.05.2026. Verfasst von Nathan Tsengele und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Goizueta Alzheimer's Disease Research Center, Emory University.
Themen: Gerontologische Pflege, Depression, Demenz
Abstract (Originalsprache)
Introduction
Previous Western studies have shown an association between neurodegenerative plasma biomarkers and geriatric depression. However, few studies have examined this relationship in sub-Saharan African countries. This article examines this association in older adults with or without clinical dementia in Kinshasa, Democratic Republic of Congo.
Methods
This cross-sectional study included eighty-one people aged 65 years and older assessed for dementia using the Community Dementia Screening Instrument (CSID) and the Alzheimer’s Disease Questionnaire. Depression and cognitive impairment were assessed using the Geriatric Depression Scale and the African Neuropsychological Battery (ANB), respectively. Plasma biomarkers measured included β-amyloid (Aβ) 40/42, phosphorylated tau 181 (p-tau), neurofilament light chain (NfL), glial fibrillar acid protein (GFAP), interleukins (IL-1β, IL-10), and tumor necrosis factor-α (TNF-α). Logistic regression models were used to estimate the likelihood that these biomarkers are associated with depression, adjusting for sex, age, and education level.
Results
The mean age of the participants was 72.9 years. Of those suspected of suffering from Alzheimer’s disease (AD), 80% had geriatric depression. High blood pressure was common in participants with suspected AD (60%). People with dementia had significantly lower cognitive scores on all ANB tests than those without dementia. GFAP and NfL were significantly associated with higher odds of geriatric depression, with odds ratios of 1.98 (1.17–3.67; p = 0.02) and 1.76 (1.06–3.20; p = 0.04), respectively. Other biomarkers were not associated with depression.
Conclusion
This study suggests a potential role of nonspecific biomarkers of AD, neurodegeneration, and astrocytic glial activation in geriatric depression in older adults in sub-Saharan Africa.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
- Faculty of Medicine, Kikwit University, Kikwit, Democratic Republic of Congo.
- Kinshasa Memory Clinic, Kinshasa, Democratic Republic of Congo.
- Faculty of Medicine, University of Bandundu, Bandudu, Democratic Republic of Congo.
- Department of Neurology, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
- Faculty of Medicine, Protestant University of Congo, Kinshasa, Democratic Republic of Congo.
Förderung
- Goizueta Alzheimer's Disease Research Center, Emory University
Zitieren
APA
Tsengele, N., Sodi Magudigana, A., Gikelekele, G., Epenge, E., Kangula, G., Vukumuna, E. M., Bilongo, A. M., Mbuku Nguala, S., Bomba, D. B., Mananga Lelo, G., N'situ Mankubu, A., & Ikanga, J. (2026). Association between neurodegenerative plasma biomarkers and geriatric depression in older adults with and without clinical dementia in Kinshasa, Democratic Republic of the Congo. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1787247
Vancouver
Tsengele N, Sodi Magudigana A, Gikelekele G, Epenge E, Kangula G, Vukumuna EM, et al. Association between neurodegenerative plasma biomarkers and geriatric depression in older adults with and without clinical dementia in Kinshasa, Democratic Republic of the Congo. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1787247
BibTeX
@article{Tsengele2026,
author = {Tsengele, Nathan and Sodi Magudigana, Alfred and Gikelekele, Guy and Epenge, Emmanuel and Kangula, Guy and Vukumuna, Eric Muteba and Bilongo, Abraham Mifundu and Mbuku Nguala, Said and Bomba, Degani Banzulu and Mananga Lelo, Gilbert and N'situ Mankubu, Adelin and Ikanga, Jean},
title = {Association between neurodegenerative plasma biomarkers and geriatric depression in older adults with and without clinical dementia in Kinshasa, Democratic Republic of the Congo},
journal = {Frontiers in Psychiatry},
year = {2026},
volume = {17},
doi = {10.3389/fpsyt.2026.1787247}
}
EUVIMED